乳酸细菌衍生的细胞外囊泡:新兴的生物活性纳米粒子在调节宿主健康方面
Mohan Li1,2, Bingyong Mao1,2, Xin Tang1,2
1State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.
Gut microbes
|November 14, 2024
概括
乳酸细菌细胞外囊泡 (LAB-EVs) 是纳米大小的囊泡,具有治疗潜力. 本综述详细介绍了它们的隔离,功能和用于疾病治疗和诊断的临床应用.
科学领域:
- 微生物学 微生物学
- 纳米技术 纳米技术
- 生物技术是生物技术.
背景情况:
- 乳酸细菌衍生细胞外囊泡 (LAB-EVs) 是纳米级生物实体,调解细胞间通信.
- 这些囊泡可以影响宿主生理和病理,通过无细胞策略提供治疗效益.
- 益生菌衍生的EV显示出对人类健康和作为药物输送纳米载体的承诺,因为它们具有穿越生物障碍的能力.
研究的目的:
- 审查LAB-EVs的隔离和净化方法.
- 阐明LAB-EVs的生物发生,货物分类和功能.
- 讨论LAB-EVs在诊断和治疗中的临床转化所面临的挑战和机会.
主要方法:
- 强调LAB-EVs的隔离和净化技术.
- 生物发生和货物分类机制的探索.
- 使用蛋白质组学等先进分析方法对LAB-EV货物的表征.
主要成果:
- LAB-EVs在细胞间通信,宿主相互作用,肠道平衡以及免疫/炎症反应中发挥作用.
- 蛋白质组学使得LAB-EV分子载荷的详细表征成为可能.
- 在临床应用的隔离,表征和安全性方面仍然存在重大挑战.
结论:
- 实验室电动车具有治疗前景,但需要进一步研究标准化的隔离,表征和安全协议.
- 了解LAB-EV与宿主之间的相互作用对于利用它们的健康益处至关重要.
- 未来的研究应该专注于克服成功临床转化目前的局限性.
相关概念视频
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K


